Department of Head and Skin

Skin Cancer Research institute Ghent (SkinCRIG)

SkinCRIG

SkinCRIG conducts clinical, translational and (psycho)social research into skin cancer including melanoma, keratinocyte cancers and rare skin cancer types. It also investigates the impact of cancer (treatment) on skin.

This includes research into:

  • social impact and prevention
  • innovating imaging, teledermatology and artificial intelligence
  • tumor immunology and microbiome
  • innovative treatments
  • psychosocial aspects
  • Skin toxicity in anticancer agents
  • ect.

Group leaders

prof. dr. Lieve Brochez (contact person)

prof. dr. Evelien Verhaeghe

prof. dr. Isabelle Hoorens

Members

Internal members

prof. dr. Barbara Boone

prof. dr. Sofie De Schepper

prof. dr. Katia Ongenae

dr. Annelies Demeyer

dr. Marc Haspeslagh

PhD students

Laura Van Coile

Veronique Clauwaert

Annick Meertens

Julie Kips

Amber Shen

Michael Saerens

Floor Verstraete

Technical staff

Els Van Maelsaeke

Fien Rapoye

Larysa Neudakh

National and international collaborations

National

International

  • EuroSkin
  • EADO (European Association of Dermato-Oncology)
  • Immuno-Oncology: ITN netwerk PRIOMIC
  • Dermatologie Rotterdam Erasmus ziekenhuis

Defended PhDs (last 5 years)

Pieter Van Molle, 2024, Ghent University / IMEC​

Integrating neural networks as diagnosis support in dermatology

Annabel Meireson, 2022, Ghent University​

Biomarkers in immuno-oncology : from melanoma to other cancer types, from tissue to liquid biopsy, from late stage to early stage disease

Evi Hulstaert, 2021, Ghent University

Exploring RNA signatures in human biofluids as novel liquid biopsy tool

Marc Haspeslagh, 2019, Ghent University

Ex vivo dermoscopy with dermdotting: a new method for lesion specific and targeted cutting​

Isabelle Hoorens, 2016, Ghent University​

The preventive landscape of skin cancer in Belgium: a clinical and health economical analysis

Inès Chevolet, 2015, Ghent University​

A translational exploration of melanoma immunology focused on indoleamine 2,3-dioxygenase: lessons for immunoprofiling and immunotherapy

Reinhart Speeckaert, 2012, Ghent University (PhD in biomedical sciences)​

Study of the mechanisms of melanocyte destruction in melanoma, halo nevi and vitiligo

Barbara Boone, 2009, Ghent University​

Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski / SnoN and EGFR​

​

​

​